Cell, Molecular, & Developmental Biology  http://www.gbs.uab.edu  http://www.uab.edu/graduate  Back to Main

Faculty Detail    
Name MYTHREYE KARTHIKEYAN
Associate Professor
 
Campus Address WTI 320B Zip 3300
Phone  (20-5) -746
E-mail  mythreye@uab.edu
Other websites https://www.mythreyelab.org
     

Education
Undergraduate  Delhi University ( 3 year degree)    1996  BSc Honors 
Graduate  University North Carolina Chapel Hill     20005  PhD 


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Pathology   Molecular & Cellular Pathology Associate Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Associate Professor

Graduate Biomedical Sciences Affiliations
Cancer Biology 
Cell, Molecular, & Developmental Biology 

Biographical Sketch 
Mythreye Karthikeyan received her doctoral training and degree from the University of North Carolina in Chapel Hill in 2005 ( Advisor: Kerry S Bloom). She initiated her postdoctoral training with Pascal Goldschmidt at Duke University before extending and completing her training with Gerard C Blobe at Duke University. She was appointed as Research Assistant Professor also at Duke between the period of 2009-2013, before accepting her first tenure track position at University of South Carolina in the fall of 2013. There, she was tenured and promoted to the rank of Associate Professor in 2019. She joined UAB's Department of Pathology in Oct 2019 and is currently a tenured Associate Professor here.

Society Memberships
Organization Name Position Held Org Link
AACR  member   
ASBMB  member   



Research/Clinical Interest
Title
Molecular and cellular mechanisms of signaling during metastasis
Description
The goal is to develop an in depth understanding of mechanisms and consequences of altered signaling in disease. Emphasis is on cellular and molecular mechanisms of tumor progression and metastasis. Our approach is cross-disciplinary interfacing with biochemistry, molecular cell biology and systems approaches . Our overall mission is to discover innovative avenues for developing therapeutics. Work is supported by two R01 grants from the National Institutes of Health.

Keywords
ovarian cancer, TGFbeta, BMP, inhibin/activin, betaglycan, cellular signaling, extracellular matrix , cell survival mechanisms